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Summary
Background.  —  Although  previous  studies  showed  that  pregnancy  with  heart  disease  is  associated
with signiﬁcant  complications,  few  focused  on  patients  with  valvular  heart  disease  in  sub-
Saharan Africa.
Methods.  —  We  report  maternal  and  foetal  outcomes  in  50  pregnant  women  with  heart  disease
admitted to  the  Department  of  Cardiology  of  the  University  of  Dakar,  during  an  8-year  period.
Results.  —  Rheumatic  heart  disease  was  observed  in  46  women,  seven  of  whom  had  previously
been operated  on.  Among  the  remaining  39,  32  had  mitral  stenosis  (isolated  or  associated
with other  valvular  lesions).  At  admission,  36  women  presented  with  pulmonary  oedema,  two
with pulmonary  embolism  and  18  with  arrhythmia.  There  were  17  maternal  deaths  (34%).
Maternal death  was  associated  with:  mitral  stenosis  (P  =  0.03);  severe  tricuspid  regurgitation
(P =  0.001);  New  York  Heart  Association  functional  class  III  or  IV  (P  =  0.001);  symptoms  of  heart
failure (P  <  0.001).  A  favourable  maternal  outcome  was  associated  with:  prior  cardiac  events
(P <  0.001);  prior  surgical  valve  replacement  (P  =  0.03);  cardiac  prosthetic  valve  (P  =  0.03).  There
were 30  live  births,  six  foetal  deaths  and  ﬁve  therapeutic  abortions;  nine  women  were  lost  to
follow-up.  Delivery  was  vaginal  in  19  out  of  30  cases  and  by  caesarean  section  in  11  cases.  Median
gestational age  at  delivery  was  28  weeks  (range,  8—38  weeks).  Five  births  occurred  preterm.
There were  four  stillbirths  (neonatal  mortality,  7.6%).
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Conclusions.  —  Heart  disease  severely  impacts  maternal  and  foetal  outcome  in  our  study.  Preg-
nant women  who  underwent  appropriate  valve  replacement  before  pregnancy  had  a  better
prognosis.
© 2011  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé
Contexte.  —  Les  études  antérieures  ont  montré  que  la  grossesse  est  associée  chez  les  femmes
atteintes de  cardiopathie  à  un  risque  de  complications  cardiaques  maternelles,  fœtales  et
néonatales.  Peu  d’entre  elles  ont  cependant  porté  sur  les  complications  gravidiques  des  car-
diopathies  rhumatismales  en  Afrique  subsaharienne.
Méthodes.  —  Nous  rapportons  l’évolution  maternelle  et  fœtale  des  grossesses  de  50  femmes
atteintes de  cardiopathies  (âge  moyen  28,4  ans  ;  18—43  ans)  admises  dans  le  service  de  cardio-
logie de  l’université  de  Dakar,  au  cours  d’une  période  de  huit  ans.
Résultats.  —  Une  cardiopathie  rhumatismale  est  observée  chez  46  femmes,  dont  sept  ont  été
opérées auparavant.  Une  sténose  mitrale,  isolée  ou  associée  à  une  autre  atteinte  valvulaire,
est présente  chez  32  des  39  autres  femmes.  À  l’admission,  36  femmes  ont  un  œdème  pul-
monaire,  deux  une  embolie  pulmonaire,  18  une  arythmie,  Onze  sont  asymptomatiques.  Un  décès
maternel survient  dans  17  cas  (34  %),  lié  à  une  insufﬁsance  cardiaque  (n  =  8),  à  une  embolie  pul-
monaire  (n  =  3),  un  choc  cardiogénique  (n  =  2)  ou  septique  (n  =  1),  une  hémorragie  (n  =  2).  Les
facteurs associés  à  la  mortalité  maternelle  sont  la  sténose  mitrale  (p  =  0,03),  l’insufﬁsance  tri-
cuspide sévère  (p  =  0,001),  une  classe  fonctionnelle  NYHA  III  ou  IV  (p  =  0,001),  des  symptômes
d’insufﬁsance  cardiaque  (p  <  0,001).  À  l’inverse,  les  facteurs  associés  au  pronostic  maternel
favorable  sont  les  antécédents  d’événements  cardiaques  préalables  (p  <  0,001),  de  remplace-
ment valvulaire  (p  =  0,03)  et  la  présence  d’une  prothèse  valvulaire  (p  =  0,03).  Les  50  grossesses
se terminent  par  la  naissance  de  30  nouveau-nés  vivants,  six  morts  fœtales  et  cinq  avortements
thérapeutiques.  Neuf  femmes  sont  perdues  de  vue.  L’accouchement  a  lieu  par  voie  naturelle
dans 19  cas  sur  30  (avec  forceps  dans  trois  cas)  et  par  césarienne  dans  11  cas.  La  médiane  d’âge
gestationnel  à  l’accouchement  est  de  28  semaines  (8—38  semaines),  avec  cinq  accouchements
prématurés  et  quatre  mort-nés.  La  mortalité  néonatale  est  de  7,6  %.  La  médiane  de  poids  à  la
naissance  des  26  nouveau-nés  survivants  est  de  2366  g  (1350—3100  g).
Conclusion.  — La  présence  d’une  cardiopathie  impacte  sévèrement  le  pronostic  maternel  et
fœtal de  la  grossesse  en  Afrique  subsaharienne,  lorsqu’une  prise  en  charge  appropriée  compre-
nant traitement  médical  et  correction  chirurgicale  préalable,  prévention,  planning  familial,
disponibilité  d’une  salle  de  cathétérisme  permettant  la  valvuloplastie  percutanée,  n’est  pas
accessible.  À  l’inverse,  les  femmes  qui  ont  bénéﬁcié  d’un  remplacement  valvulaire  dans  leurs
antécédents  ont  un  meilleur  pronostic  gravidique.
© 2011  Elsevier  Masson  SAS.  Tous  droits  réservés.
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NYHA  New  York  Heart  Association
VHD  valvular  heart  disease
Background
Circulatory  changes  during  pregnancy  may  result  in  adverse
maternal  and  foetal  outcomes  in  women  with  heart  disease.
Circulating  blood  volume,  cardiac  output  and  heart  rate
increase  progressively  after  the  ﬁrst  trimester,  and  worsen
during  the  uterine  contractions  of  labour  and  subsequent
delivery  [1].Previous  studies  performed  in  Western  countries  have
shown  that  pregnancy  in  women  with  heart  disease  is  asso-
ciated  with  signiﬁcant  cardiac  and  neonatal  complications,
despite  state-of-the-art  obstetric  and  cardiac  care  [2—6].
d
i
m
ﬁisk factors  associated  with  an  unfavourable  outcome  have
een  recognized,  and  include  older  age,  tobacco  smoking,
ultiple  gestations,  anticoagulant  therapy,  poor  functional
lass,  cyanosis  and  left  heart  obstruction  [2—6]. However,
nly  a  few  reports  have  focused  speciﬁcally  on  pregnancy
utcome  in  women  with  valvular  heart  disease  (VHD)  [7—9],
specially  in  lower-income  countries  [10].
Sub-Saharan  Africa  is  characterized  by  a  high  preva-
ence  of  rheumatic  fever  and  rheumatic  VHD.  Prevalence
f  rheumatic  heart  disease  has  been  estimated  at  two  to
hree  cases  per  1000  among  school-age  children  in  Africa
ho  underwent  clinical  screening  [11,12]  and  was  recently
eported  to  be  about  10-fold  higher  if  they  also  had  an
ltrasound  examination  [12,13].  The  spectrum  of  the  dis-
ase  in  sub-Saharan  Africa  also  includes  severe  valvular
isease  in  patients  who  have  previously  been  operated  on,
n  some  of  those  receiving  anticoagulant  therapy,  and  in
any  others  who  have  declined  surgery,  mainly  because  of
nancial  constraints.  In  many  instances,  lack  of  ﬁnancial
3 M.  Diao  et  al.
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Table  1  Rheumatic  heart  disease  of  native  valves  in  39
pregnant  women.
Valvular  disease
observed
n  (%)
Single  cardiac  valve
involvement  (n  =  12;
30.7%)
MS  7  (18)
MR  +  MS  3  (7.7)
MR  1  (2.5)
AR  1  (2.5)
Multiple  cardiac  valve
involvement  (n  =  27;
69.3%)
MS  +  TR 9 (23)
MS  +  MR  +  TR 6 (15)
MR  +  TR 3 (7.7)
MS  +  MR  +  AR  +  TR  3  (7.7)
AR  +  MR 2  (5)
MS  +  AR  1  (2.5)
MS  +  AR  +  TR 1 (2.5)
MS  +  AS  +  AR 1 (2.5)
MR  +  AR  +  TR 1 (2.5)
AR: aortic regurgitation; AS: aortic stenosis; MR: mitral
regurgitation; MS: mitral stenosis; TR: tricuspid regurgitation.
3
4
o
v
v
n
i
c
o
p
n
i
u
w
M
A
o
(
i
ﬁ
c
p
c
d
1
a
s72  
upport,  lack  of  information  about  the  risks  of  pregnancy
n  women  with  heart  disease,  and  social  and  cultural  draw-
acks  preclude  any  appropriate  prevention  strategy.  As  a
esult,  management  of  pregnancy  in  such  patients  remains
 medical  challenge  in  most  low-income  African  countries.
In  this  study,  we  report  maternal  and  foetal  outcomes
n  50  pregnant  women  with  heart  disease  admitted  to  the
epartment  of  Cardiology  of  the  University  of  Dakar,  Sene-
al.
ethods
he  study  was  a  retrospective  evaluation  of  pregnancy
utcome  in  women  with  heart  disease.  All  cases  were
ollowed  during  pregnancy,  labour  and  delivery  at  the  Uni-
ersity  Hospital  of  Dakar,  Senegal,  between  February  1996
nd  February  2004.  Exclusion  criteria  included:  therapeutic
bortion  for  non-cardiac  reasons;  miscarriage  (foetal  loss
efore  20  weeks’  gestation);  hypertensive  heart  disease;
nd  peripartum  cardiomyopathy.
Clinical  data  were  recorded  at  the  ﬁrst  prenatal  visit,
ncluding:  age;  occupational,  educational  and  marital  sta-
us;  gestational  age;  parity  status;  cardiac  conditions,  prior
ardiac  events  and  therapy;  NYHA  functional  class;  cyanosis;
omorbid  conditions;  and  anaemia.
Treatment  and  outcome  data  were  obtained  during
ospitalization.  Prepartum,  peripartum  and  postpartum
omplications  were  grouped  into  cardiac,  neonatal  or
bstetric  events.  The  mode  of  delivery  and  obstetric
omplications  were  documented.
Data  were  analysed  to  evaluate  maternal  and  foetal  out-
omes.  Criteria  to  evaluate  maternal  outcome  included:
yspnoea;  NYHA  functional  class;  congestive  heart  fail-
re;  and  new  onset  or  exacerbated  arrhythmia.  Neonatal
omplications  were  deﬁned  as:  premature  birth  (<  37  weeks’
estation);  small-for-gestational-age  birth  weight  (<  10th
ercentile  for  gestational  age);  neonatal  and  respiratory
istress  syndrome  using  the  Apgar  score;  foetal  death
>  20  weeks’  gestation  before  death);  and  neonatal  death
occurring  between  birth  and  age  28  days).
tatistical analysis
ontinuous  values  are  presented  as  means  (standard  devi-
tions)  and  were  compared  using  a  non-paired  t  test.
omparisons  of  baseline  characteristics  and  maternal  out-
ome  were  made  using  the  Chi2 test.  Statistical  signiﬁcance
as  accepted  at  the  95%  conﬁdence  level  (P  <  0.05).
esults
uring  the  8-year  study  (February  1996  to  February  2004),  50
regnant  women  with  heart  disease  were  included,  account-
ng  for  2.7%  of  patients  hospitalized  in  the  Department
f  Cardiology  during  the  same  period.  The  mean  age  of
he  women  was  28.4  years  (range:  18—43  years).  Forty-ﬁve
omen  (90%)  had  low  educational  status  (no  school  or  pri-
ary  school  only)  and  low  socioeconomic  status  (income  less
han  2.5  $  per  day);  only  three  women  (6%)  were  engaged  in
ny  professional  occupation.
a
p
dPrevious  heart  disease  was  known  before  pregnancy  in
7  women  (74%),  with  a  mean  follow-up  of  6.5  years  (range:
 months  to  30  years).
Rheumatic  VHD  was  the  predominant  cardiac  condition,
bserved  in  46  women  (92%),  of  whom  seven  (16%)  had  pre-
iously  been  surgically  treated  with  prosthetic  mechanical
alve  replacement.  Among  the  remaining  39  women  with
on-surgically-corrected  VHD,  32  had  mitral  stenosis  (76%),
ncluding  seven  isolated  forms  of  mitral  stenosis,  three  asso-
iated  with  mitral  regurgitation  and  22  associated  with  any
ther  valvular  lesions  (Table  1).
The  remaining  heart  diseases  were  congenital  in  three
atients  (tetralogy  of  Fallot,  n  =  1;  ventricular  septal  defect,
 =  1;  pulmonary  stenosis,  n  =  1)  and  one  patient  had
schaemic  heart  disease.  A  history  of  congestive  heart  fail-
re  was  documented  in  14  women  (28%).  In  addition,  one
oman  (2%)  had  had  a  previous  stroke.
aternal outcome
t  admission,  36  women  (72%)  presented  with  pulmonary
edema,  two  (4%)  with  pulmonary  embolism,  and  only  11
22%)  were  asymptomatic.  Cardiac  arrhythmia  was  observed
n  18  women  (36%),  including  nine  patients  with  atrial
brillation,  four  with  atrial  ﬂutter  and  one  with  atrial  tachy-
ardia.  Ventricular  premature  beats  were  observed  in  11
atients  (22%).  No  patient  presented  with  ventricular  tachy-
ardia.
All  women  required  cardiovascular  medication,  including
iuretics  (n  =  23;  46%),  nitrates  (n  =  22;  44%),  digoxin  (n  =  8;
6%)  and  beta-blockers  (n  =  1;  2%).  Anticoagulants  were
dministered  to  30  patients  (60%).  An  electrical  cardiover-
ion,  performed  in  three  patients,  restored  sinus  rhythm  in
ll  three  cases.  No  surgical  or  percutaneous  intervention  was
erformed.
Seventeen  maternal  deaths  (34%)  occurred,  including  six
uring  the  second  trimester  and  11  in  the  postpartum  period.
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Table  2  Predictors  of  adverse  outcome  (maternal  death)  in  46  pregnant  women  with  rheumatic  valvular  disease.
Adverse  outcome  (n  =  17)  Favourable  outcome  (n  =  29)  P
Age  (years)a 29.1  (4.7)  28.8  (4.9)  0.79
Parity,  n  (%)a 2.52  (2.1)  1.7  (1.8)  0.26
Prior  adverse  cardiac  eventsb 3  (17.6)  22  (75.8)  <  0.001
Prior  valvular  interventionb 0  (0)  7  (24.1)  0.03
Prosthetic  valveb 0  (0)  7  (24.1)  0.03
Mitral  stenosisb 15  (88.2)  17  (58.6)  0.03
Mitral  regurgitationb 7  (41.1)  13  (44.8)  0.9
Aortic  regurgitationb 3  (17.6)  11  (37.9)  0.15
Severe  tricuspid  regurgitationb 14  (82.3)  10  (34.4)  0.001
NYHA  functional  class  III  or  IVb 16  (94.1)  14  (48.2)  0.001
Atrial  ﬁbrillationb 8  (47.0)  8  (27.5)  0.15
Heart  failureb 17  (100)  7  (24.1)  <  0.001
Anticoagulant  therapyb 12  (70.5)  18  (62.0)  0.6
NYHA: New York Heart Association.
a Data are mean (standard deviation).
b Data are number (%).
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pThe  causes  of  maternal  deaths  were:  heart  failure  (n  =  8;
47%),  pulmonary  embolism  (n  =  3;  17%),  cardiogenic  shock
(n  =  2;  12%),  septic  shock  (n  =  2;  12%)  and  fatal  haemor-
rhage  (n  =  2;  12%),  including  one  intracranial  bleed  due  to  an
arteriovenous  malformation  rupture  and  one  haemothorax
following  pleural  puncture.
Characteristics  predictive  of  an  adverse  cardiac  outcome
during  pregnancy  were  assessed  in  women  with  rheumatic
heart  disease  only,  to  avoid  heterogeneity  (Table  2).  Mater-
nal  death  (n  =  17)  occurred  in  women  with  mitral  stenosis
predominantly  (15/17).  In  univariate  analysis,  maternal
death  was  associated  with  mitral  stenosis  (P  =  0.03),  severe
tricuspid  regurgitation  (P  =  0.001),  NYHA  functional  class  III
or  IV  (P  =  0.001)  or  symptoms  of  heart  failure  (P  <  0.001).
Conversely,  a  favourable  maternal  outcome  was  associ-
ated  with  prior  cardiac  events  (P  <  0.001),  prior  surgical
valve  replacement  (P  =  0.03)  or  a  cardiac  prosthetic  valve
(P  =  0.03).
Obstetric and foetal outcomes
Among  the  50  pregnant  women  included,  mean  parity  was  2
(range:  0—8).  The  50  pregnancies  resulted  in  30  live  births
(60%),  six  foetal  deaths  and  ﬁve  therapeutic  abortions  during
the  second  trimester.  Nine  women  were  lost  to  follow-up
after  the  initial  visit.
The  mode  of  delivery  was  vaginal  in  19  of  30  cases  (63%),
including  forceps  delivery  in  three  cases.  Caesarean  sections
were  performed  in  11  cases  (37%),  associated  with  a  tubal
ligation  for  subsequent  contraceptive  purpose  in  six  cases.
Among  the  30  women  who  gave  birth,  the  median  ges-
tational  age  at  delivery  was  28  weeks  (range:  8—38  weeks).
Five  births  occurred  preterm.  There  were  four  stillbirths,
accounting  for  a  neonatal  mortality  of  7.6%.  The  median
birth  weight  of  the  26  babies  born  alive  was  2364  g  (range:
1350—3100  g);  their  mean  Apgar  score  was  7/10.  Neonatal
hypotrophy  was  present  in  11  newborns  (42.3%),  with  a  mean
weight  of  1414  g  (range:  1350—2450  g).
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piscussion
revious  studies  in  industrialized  countries  have  identiﬁed
he  increased  risk  associated  with  pregnancy  in  women
ith  heart  disease,  depending  on  the  underlying  car-
iac  condition  and  the  presence  of  risk  factors  such  as
lder  age,  tobacco  smoking,  multiple  gestations,  antico-
gulant  therapy,  poor  functional  class,  cyanosis  and  left
eart  obstruction  [2—6,8]. However,  even  in  this  setting,
nfavourable  maternal  and  foetal  outcomes  occur  only  in
 small  proportion  of  cases.  Maternal  death  was  reported  in
hree  over  599  pregnancies  in  women  with  unselected  heart
isease  [6]  and  one  over  64  pregnant  women  with  VHD  [8].
evere  non-fatal  maternal  cardiovascular  events  occurred  in
3%  of  pregnant  women  with  unselected  heart  disease  in  the
tudy  by  Siu  et  al.  [6],  and  in  11%  of  women  with  congenital
eart  disease  [3].  Also,  foetal  or  neonatal  death  occurred  in
bout  3%  of  pregnancies  in  women  with  miscellaneous  uns-
lected  heart  disease  [5],  in  4%  with  congenital  disease  [3],
n  3%  with  dilated  cardiomyopathy  [4]  and  in  3%  with  VHD
8,9].
In  the  present  retrospective  descriptive  study  performed
n  a  tertiary-care  university  hospital  in  Senegal,  the  mater-
al  and  foetal  outcomes  of  pregnancy  in  women  with
eart  disease  appear  substantially  worse,  with  mater-
al  and  neonatal  mortality  rates  reaching  34%  and  7.6%,
espectively.  The  prominent  underlying  cardiac  disease
as  rheumatic  valvular  disease,  especially  mitral  stenosis,
bserved  in  most  instances.  However,  although  percu-
aneous  balloon  valvuloplasty  has  been  reported  to  be
ffective  in  the  treatment  of  mitral  or  aortic  stenosis  during
regnancy  [7],  this  approach  was  unfortunately  not  available
n  our  institution.  Also,  the  patients  included  belonged  to
igh-risk  groups,  as  28%  had  a  history  of  heart  failure  and  54%
resented  with  worsened  heart  failure  symptoms,  including
2%  with  pulmonary  oedema.  Arrhythmia  and/or  left  atrial
nlargement  were  present  in  two  thirds  of  women.
Consistent  with  previous  studies  on  maternal  outcome  in
regnant  women  with  heart  disease,  the  factors  predictive
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[74  
f  maternal  death  in  our  series  were  mitral  stenosis,  severe
ricuspid  regurgitation,  NYHA  functional  class  III  or  IV,  and
eart  failure.  In  contrast  with  previous  studies,  women  with
 history  of  cardiac  events  and  those  with  a  cardiac  valve
rosthesis  had  a  better  outcome.  Also,  anticoagulant  ther-
py  was  not  associated  with  an  increased  risk  of  death.  This
nexpected  ﬁnding  may  result  from  the  knowledge  that  the
atients  and  the  physicians  in  charge  of  them  had  about
he  disease.  Indeed,  although  the  baseline  proportion  of
atients  who  were  aware  of  their  heart  disease  was  74%,  it  is
ikely  that  patients  with  previous  cardiac  events  or  surgery
ere  more  inclined  to  seek  medical  assistance  for  preg-
ancy  and  subsequent  delivery  than  less-informed  women
r  those  with  limited  access  to  medical  care.  Also,  women
ith  moderate  or  neglected/denied/misinterpreted  symp-
oms  of  a  previously  unknown/untreated  mitral  stenosis  may
ave  worsened  during  the  last  weeks  of  pregnancy  and  pre-
ented  for  admission  to  an  obstetrical  facility  with  severe
eart  failure  symptoms.
Faced  with  these  shortcomings,  educational  and  socioe-
onomic  status  considerations  should  be  taken  into  account.
n  our  study,  most  women  had  a  very  low  educational  sta-
us  and  were  unable  to  recognize  the  risks  associated  with
heir  cardiac  disease  and  the  related  risk  of  pregnancy.
nly  few  received  appropriate  prior  counselling  or  contra-
eption.  One  should  also  consider  the  potential  impact  of
ndividual  discrepancies  between  women  who  were  previ-
usly  operated  on  —which  requires  ﬁnancial  support  and
 substantial  income  in  Africa  — and  women  with  severe
ntreated  rheumatic  heart  disease  without  previous  car-
iac  adverse  events,  to  whom  disease  knowledge  or  surgery
ould  be  denied  due  to  ﬁnancial  constraints.
The  lower  mortality  rate  observed  among  women  who
ad  undergone  previous  cardiac  valve  replacement  —  and
lso  among  those  who  received  anticoagulant  therapy  —  con-
rasts  with  the  results  of  previous  studies  that  reported  an
ncreased  risk  in  this  subset  of  patients.  In  fact,  in  our  study,
he  prominent  risk  factor  for  maternal  death  was  untreated
heumatic  heart  disease,  mainly  mitral  stenosis,  for  which
alvular  repair,  either  surgical  or  by  percutaneous  balloon
alvuloplasty,  was  the  procedure  of  choice  to  prevent  clini-
al  deterioration  during  the  third  trimester  of  pregnancy  or
uring  labour.
onclusion
he  present  study  demonstrates  that  rheumatic  heart
isease  severely  impacts  maternal  and  foetal-perinatal  out-
ome  in  sub-Saharan  Africa,  when  appropriate  management,
ncluding  percutaneous  interventions,  outpatient  medical
herapy  and  prevention,  is  not  available.  Increased  maternal
orbidity  was  reﬂected  by  a  high  incidence  of  symptomatic
eart  failure  and  poorly  tolerated  arrhythmias.  Maternal
nd  foetal-perinatal  mortality  rates  were  higher  than  those
bserved  in  most  other  studies,  including  African  studies  in
hich  appropriate  family  planning,  optimized  cardiac  state
rior  to  conception  and  cardiac  percutaneous  interven-
ions  were  performed  [9].  Accordingly,  this  study  indicates
[M.  Diao  et  al.
he need  for  maternal  cardiac  evaluation  and  management
efore  conception  and  during  pregnancy  in  these  high-risk
omen.  Repair  of  VHD,  mainly  mitral  stenosis,  should  be
erformed  prior  to  pregnancy,  if  possible.  Catheterization
nd  percutaneous  balloon  valvuloplasty  facilities  should  be
vailable  in  cardiology  departments  associated  with  medi-
al  universities  located  in  high  rheumatic  fever  prevalence
reas.
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